Vertaling van "alzheimer’s disease caregivers " (Nederlands → Frans) :

Alzheimer’s Disease Caregivers Identify Memory Loss, Personal Safety And Confusion As Top Three Concerns Related To Progression Of Their Loved One’s Disease
Alpine Mountaineer And Alzheimer’s Advocate To Climb Highest Peak On Each Continent To Raise Awareness Of Growing Prevalence And Burden Of Alzheimer’s Disease

National Survey Co-Sponsored by Alzheimer’s Foundation of America, Eisai and Pfizer Sheds Light on Difficulties Faced by America’s Alzheimer’s Disease Caregivers
National Survey Co- Sponsored by Alzheimer’s Foundation of America , Eisai and Pfizer Sheds Light on Difficulties Faced by America’s Alzheimer’s Disease Caregivers

Exelon/Exelon Patch (USD 815 million, +24% lc), a therapy for mild to moderate forms of Alzheimer’s disease dementia and also dementia linked with Parkinson’s disease, has experienced renewed growth following the introduction of the once-daily Exelon Patch formulation in late 2007 that quickly gained broad acceptance by patients and caregivers.
Exelon/Exelon Patch (USD 815 millions, +24% en m. l.), traitement des formes légères à modérées de la maladie d'Alzheimer et de la démence associée à la maladie de Parkinson, a renoué avec la croissance à la suite de l’introduction, à fin 2007, de l’Exelon Patch, un patch transdermique à renouveler une fois par jour, qui a été rapidement accepté à une grande échelle par les patients et les soignants.